肝硬化脾亢脾切除术后门静脉血栓形成影响因素

doi:10.3877/cma.j.issn.2095-3232.2024.01.008

目的

探讨肝硬化脾功能亢进症（脾亢）脾切除术后门静脉血栓形成（PVT）的危险因素。

方法

回顾性分析2016年7月至2019年4月于中山大学附属第三医院行脾切除术的136例肝硬化脾亢患者临床资料。其中男101例，女35例；平均年龄为（48±11）岁。病毒性肝炎113例，肝豆状核变性8例。患者均签署知情同意书，符合医学伦理学规定。根据术后有无发生PVT，将患者分为PVT组（77例）和非PVT组（59例）。收集患者围手术期临床相关指标，采用单因素和Logistic多因素回归分析PVT形成的危险因素，ROC曲线分析危险因素诊断最佳界值。

结果

肝硬化脾亢脾切除术后PVT发生率57%（77/136），75%（58/136）的PVT发生在术后10 d内。单因素分析显示，内镜治疗史、术前凝血酶时间（TT）、脾脏长径、脾肋间厚径、门静脉内径、术前脾静脉内径和术后门静脉内径、手术当天及术后5～6 d RBC、手术当天Plt、术后2～4 d TT与术后PVT发生有关（P<0.05）。Logistic多因素分析显示，内镜治疗史、手术当天Plt、术后门静脉内径是术后PVT发生的独立影响因素（OR=3.556，1.020，1.449；P<0.05）。ROC曲线分析显示，手术当天Plt>62×10⁹/L诊断术后PVT的敏感度0.597，特异度0.593；术后门静脉内径>13.5 mm诊断术后PVT的敏感度0.390，特异度0.864。

结论

肝硬化脾亢脾切除术后PVT发生率较高，术后门静脉内径>13.5 mm、术后当天Plt>62×10⁹/L及内镜治疗史是肝硬化脾亢脾切除术后发生PVT的独立危险因素。

关键词: 门静脉血栓, 肝硬化, 脾切除术, 脾功能亢进, 危险因素, 门静脉内径, 血小板

Objective

To investigate the risk factors of portal vein thrombosis (PVT) after splenectomy in patients with cirrhotic hyperplenism.

Methods

Clinical data of 136 cirrhosis patients complicated with hypersplenism who underwent splenectomy in the Third Affiliated Hospital of Sun Yat-senUniversity from July 2016 to April 2019 were retrospectively analyzed. Among them, 101 patients were male and 35 female, aged (48±11) years on average. 113 cases were diagnosed with viral hepatitis and 8 cases of hepatolenticular degeneration. The informed consents of all patients were obtained and the local ethical committee approval was received. According to postoperative incidence of PVT, all patients were divided into the PVT (n=77) and non-PVT groups (n=59). Clinical indexes were collected during perioperative period. The risk factors of PVT were analyzed by univariate and multivariate Logistic regression analyses, and the optimal diagnostic threshold values of risk factors were analyzed by the ROC curve.

Results

The incidence of PVT was 57%(77/136) after splenectomy in patients with cirrhotic hyperplenism, and 75%(58/136) occurred within 10 d after splenectomy. Univariate analysis showed that endoscopic treatment history, preoperative thrombin time (TT), splenic maximum diameter, splenic intercostal thickness, portal vein diameter, preoperative splenic vein diameter and postoperative portal vein diameter, RBC on the day of surgery and 5-6 d after surgery, Plt on the day of surgery, and TT on 2-4 d after surgery were correlated with the incidence of postoperative PVT (P<0.05). Multivariate Logistic analysis showed that endoscopic treatment history, Plt on the day of surgery, and portal vein diameter were the independent factors influencing the incidence of postoperative PVT (OR=3.556, 1.020, 1.449; P<0.05). ROC curve revealed that the sensitivity and specificity of Plt>62×10⁹/L on the day of surgery in the diagnosis of postoperative PVT were 0.597 and 0.593. The sensitivity and specificity of postoperative portal vein diameter>13.5 mm in the diagnosis of postoperative PVT were 0.390 and 0.864.

Conclusions

The incidence of PVT after splenectomy in patients with cirrhotic hyperplenism is relatively high. Postoperative portal vein diameter>13.5 mm, Plt>62×10⁹/L on the day of surgery and endoscopic treatment history are the independent risk factors for PVT after splenectomy.

Key words: Portal vein thrombosis, Liver cirrhosis, Splenectomy, Hypersplenism, Risk factors, Diameter of portal vein, Platelet

表1 肝硬化脾亢脾切除患者术后PVT的单因素分析

因素	PVT组	非PVT组	统计值	P值
内镜治疗史（例）	44	15	χ²=13.68	<0.001
术前TT [s，M（Q₁，Q₃）]	17.3（16.5，17.8）	17.6（17.2，18.4）	Z=-2.50	0.012
脾脏长径[mm，M（Q₁，Q₃）]	178（163，201）	172（156，180）	Z=2.34	0.019
脾肋间厚径[mm，M（Q₁，Q₃）]	63（55，71）	59（53，64）	Z=2.42	0.016
术前门静脉内径[mm，M（Q₁，Q₃）]	14（13，16）	13（10，14）	Z=3.31	0.001
术前脾静脉内径[mm，M（Q₁，Q₃）]	12（10，14）	11（9，12）	Z=2.58	0.009
术后门静脉内径（mm，±s）	13.3±2.5	12.1±1.5	t=3.20	0.002
手术当天RBC（×10¹²/L，±s）	4.1±0.8	3.8±0.8	t=-2.31	0.022
手术当天Plt [×10⁹/L，M（Q₁，Q₃）]	66（49，87）	57（42，71）	Z=2.27	0.023
术后第5～6 d RBC（×10¹²/L，±s）	3.7±0.9	3.5±0.8	t=2.33	0.021
术后第2～4 d TT [s，M（Q₁，Q₃）]	14.9（14.3，15.8）	15.5（14.9，16.2）	Z=-2.88	0.004

表1 肝硬化脾亢脾切除患者术后PVT的单因素分析

因素	PVT组	非PVT组	统计值	P值
内镜治疗史（例）	44	15	χ²=13.68	<0.001
术前TT [s，M（Q₁，Q₃）]	17.3（16.5，17.8）	17.6（17.2，18.4）	Z=-2.50	0.012
脾脏长径[mm，M（Q₁，Q₃）]	178（163，201）	172（156，180）	Z=2.34	0.019
脾肋间厚径[mm，M（Q₁，Q₃）]	63（55，71）	59（53，64）	Z=2.42	0.016
术前门静脉内径[mm，M（Q₁，Q₃）]	14（13，16）	13（10，14）	Z=3.31	0.001
术前脾静脉内径[mm，M（Q₁，Q₃）]	12（10，14）	11（9，12）	Z=2.58	0.009
术后门静脉内径（mm，±s）	13.3±2.5	12.1±1.5	t=3.20	0.002
手术当天RBC（×10¹²/L，±s）	4.1±0.8	3.8±0.8	t=-2.31	0.022
手术当天Plt [×10⁹/L，M（Q₁，Q₃）]	66（49，87）	57（42，71）	Z=2.27	0.023
术后第5～6 d RBC（×10¹²/L，±s）	3.7±0.9	3.5±0.8	t=2.33	0.021
术后第2～4 d TT [s，M（Q₁，Q₃）]	14.9（14.3，15.8）	15.5（14.9，16.2）	Z=-2.88	0.004

表2 肝硬化脾亢脾切除患者术后PVT的Logistic多因素回归分析

变量	b	SE（b）	Wald χ²	OR	95%CI	P
内镜治疗史	1.271	0.401	9.998	3.556	1.621～7.843	0.001
手术当天Plt	0.200	0.008	5.783	1.020	1.004～1.037	0.016
术后门静脉内径	0.371	0.115	10.329	1.449	1.156～1.816	0.002

表2 肝硬化脾亢脾切除患者术后PVT的Logistic多因素回归分析

变量	b	SE（b）	Wald χ²	OR	95%CI	P
内镜治疗史	1.271	0.401	9.998	3.556	1.621～7.843	0.001
手术当天Plt	0.200	0.008	5.783	1.020	1.004～1.037	0.016
术后门静脉内径	0.371	0.115	10.329	1.449	1.156～1.816	0.002

图1 手术当天Plt及术后门静脉内径预测术后PVT的ROC曲线注：PVT为门静脉血栓形成

表3 手术当天Plt及术后门静脉内径预测肝硬化脾切除术后PVT的诊断效能

危险因素	AUC	P	95%CI	最佳界值
手术当天Plt	0.614	0.023	0.519～0.708	62×10⁹/L
术后门静脉内径	0.653	0.002	0.561～0.744	13.5 mm

表3 手术当天Plt及术后门静脉内径预测肝硬化脾切除术后PVT的诊断效能

危险因素	AUC	P	95%CI	最佳界值
手术当天Plt	0.614	0.023	0.519～0.708	62×10⁹/L
术后门静脉内径	0.653	0.002	0.561～0.744	13.5 mm

[1]	Weledji EP. Benefits and risks of splenectomy[J]. Int J Surg, 2014, 12(2):113-119.
[2]	Coco D, Leanza S. Indications for surgery in non-traumatic spleen disease[J]. Open Access Maced J Med Sci, 2019, 7(17):2958-2960.
[3]	Boyer TD, Habib S. Big spleens and hypersplenism: fix it or forget it?[J]. Liver Int, 2015, 35(5):1492-1498.
[4]	Hayashi H, Takamura H, Yamaguchi Y, et al. Recent role of Hassab's operation for cirrhotic patients: combination with endoscopic procedure for varices[J]. Asian J Surg, 2012, 35(2):57-61.
[5]	Zhang Y, Wei F, Wei Z, et al. Elective splenectomy combined with modified Hassab's or sugiura procedure for portal hypertension in decompensated cirrhosis[J]. Can J Gastroenterol Hepatol, 2019:1208614.
[6]	Qi X, Han G, Ye C, et al. Splenectomy causes 10-fold increased risk of portal venous system thrombosis in liver cirrhosis patients[J]. Med Sci Monit, 2016(22):2528-2550.
[7]	Zhang Y, Xu B, Wang X, et al. Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation[J]. Clin Gastroenterol Hepatol, 2020, 18(11):2564-2572, e2561.
[8]	de'Angelis N, Abdalla S, Lizzi V, et al. Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy[J]. Surgery, 2017, 162(6):1219-1230.
[9]	Kuroki T, Kitasato A, Tokunaga T, et al. Predictors of portal and splenic vein thrombosis after laparoscopic splenectomy: a retrospective analysis of a single-center experience[J]. Surg Today, 2018, 48(8):804-809.
[10]	Jiang GQ, Bai DS, Chen P, et al. Risk factors for portal vein system thrombosis after laparoscopic splenectomy in cirrhotic patients with hypersplenism[J]. J Laparoendosc Adv Surg Tech A, 2016, 26(6):419-423.
[11]	Kinjo N, Kawanaka H, Akahoshi T, et al. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension[J]. Br J Surg, 2010, 97(6):910-916.
[12]	Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis[J]. Gastroenterology, 2019, 156(6):1582-1599, e1581.
[13]	Basit SA, Stone CD, Gish R. Portal vein thrombosis[J]. Clin Liver Dis, 2015, 19(1):199-221.
[14]	Ikeda M, Sekimoto M, Takiguchi S, et al. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy[J]. Ann Surg, 2005, 241(2):208-216.
[15]	Loudin M, Ahn J. Portal vein thrombosis in cirrhosis[J]. J Clin Gastroenterol, 2017, 51(7):579-585.
[16]	Wu S, Wu Z, Zhang X, et al. The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization[J]. Turk J Gastroenterol, 2015, 26(5):423-428.
[17]	Valla DC, Rautou PE. The coagulation system in patients with end-stage liver disease[J]. Liver Int, 2015, 35 Suppl 1:139-144.
[18]	Wolberg AS, Aleman MM, Leiderman K, et al. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited[J]. Anesth Analg, 2012, 114(2):275-285.
[19]	Sato M. Effects of endoscopic variceal ligation on systemic and splanchnic hemodynamics in patients with cirrhosis[J]. Kurume Med J, 1997, 44(3):191-199.
[20]	Lo GH, Liang HL, Lai KH, et al. The impact of endoscopic variceal ligation on the pressure of the portal venous system[J]. J Hepatol, 1996, 24(1):74-80.
[21]	Lee E, Kim YJ, Goo DE, et al. Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices[J]. World J Gastroenterol, 2016, 22(11):3212-3219.
[22]	Ramanathan S, Khandelwal N, Kalra N, et al. Correlation of HVPG level with CTP score, MELD score, ascites, size of varices, and etiology in cirrhotic patients[J]. Saudi J Gastroenterol, 2016, 22(2):109-115.
[23]	Li MX, Zhang XF, Liu ZW, et al. Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(5): 512-519.
[24]	徐祺林, 郝少欢, 冉博. 肝硬化脾切除术后门静脉系统血栓形成的危险因素分析[J]. 实用肝脏病杂志, 2019, 22(5):708-711.
[25]	李山山, 周元龙, 杨季红, 等. 脾切除联合贲门周围血管离断术后门静脉系统血栓形成的危险因素分析[J]. 河北医药, 2019, 41(7):1046-1050.
[26]	Wu Y, Li H, Zhang T, et al. Splanchnic vein thrombosis in liver cirrhosis after splenectomy or splenic artery embolization: a systematic review and meta-analysis[J]. Adv Ther, 2021, 38(4):1904-1930.
[27]	张宇, 文天夫, 陈哲宇, 等. 术前门静脉血流速度在门静脉高压症断流术后血栓形成中的预测价值[J]. 中华外科杂志, 2009(11):825-828.
[28]	Stine JG, Wang J, Shah PM, et al. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study[J]. Liver Int, 2018, 38(1):94-101.
[29]	Kawanaka H, Akahoshi T, Kinjo N, et al. Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension[J]. Br J Surg, 2014, 101(12):1585-1593.
[30]	Bai DS, Zhou BH, Qian JJ, et al. Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: a 2-year prospective study[J]. Surg Endosc, 2020, 34(11):5074-5082.
[31]	尹修才, 王辉. 腹腔镜巨脾切除治疗肝硬化门静脉高压的效果观察[J/OL]. 中华普外科手术学杂志(电子版), 2020, 14(3):314-317.
[32]	Zhang H, Zhang S, Zhang J, et al. Improvement of human platelet aggregation post-splenectomy with paraesophagogastric devascularization in chronic hepatitis B patients with cirrhotic hypersplenism[J]. Platelets, 2020, 31(8):1019-1027.
[33]	Lv YF, Li XQ, Gong XG, et al. Effect of surgery treatment on hypersplenism caused by cirrhotic portal hypertension[J]. Minerva chirurgica, 2013, 68(4):409-413.
[34]	Yang L, Zhang Z, Zheng J, et al. Long-term outcomes of oesophagogastric devascularization and splenectomy in patients with portal hypertension and liver cirrhosis[J]. ANZ J Surg, 2020, 90(11):2269-2273.
[35]	Szasz P, Ardestani A, Shoji BT, et al. Predicting venous thrombosis in patients undergoing elective splenectomy[J]. Surg Endosc, 2020, 34(5):2191-2196.
[36]	Huang D, Tao M, Cao L, et al. Risk factors and anticoagulation effects of portal vein system thrombosis after laparoscopic splenectomy in patients with or without cirrhosis[J]. Surg Laparosc Endosc Percutan Tech, 2019, 29(6):498-502.
[37]	热那特·克力木, 吐尔干艾力·阿吉, 邵英梅. 肝硬化并发门静脉血栓患者临床特征及其危险因素分析[J]. 实用肝脏病杂志, 2020, 23(3):401-404.
[38]	Lippi G, Favaloro EJ. Venous and arterial thromboses: two sides of the same coin?[J]. Semin Thromb Hemost, 2018, 44(3):239-248.
[39]	Wolberg AS. Fibrinogen and factor XⅢ: newly recognized roles in venous thrombus formation and composition[J]. Curr Opin Hematol, 2018, 25(5):358-364.
[40]	Byrnes JR, Duval C, Wang Y, et al. Factor XⅢa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking[J]. Blood, 2015, 126(16):1940-1948.
[41]	Matsui T, Usui M, Wada H, et al. Platelet activation assessed by glycoprotein vi/platelet ratio is associated with portal vein thrombosis after hepatectomy and splenectomy in patients with liver cirrhosis[J]. Clin Appl Thromb Hemost, 2018, 24(2):254-262.

[1]	王振宇, 张洪美, 荆琳, 何名江, 闫奇. 膝骨关节炎相关炎症因子与血浆代谢物间的因果关系及中介效应[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 467-473.
[2]	李亚龙, 王星童, 申传安. 异体富血小板血浆在创面修复中的临床应用进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 541-545.
[3]	母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[4]	贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[5]	林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[6]	王浩源, 汪海洋, 孙建明, 陈以宽, 祁小桐, 唐博. 腹腔镜与开放修补对肝硬化腹外疝患者肝功能及凝血的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 654-659.
[7]	杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[8]	周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[9]	蔡艺丹, 方坚, 张志强, 陈莉, 张世安, 夏磊, 阮梅, 李东良. 经颈静脉肝内门体分流术对肝硬化门脉高压患者肠道菌群及肝功能的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 285-293.
[10]	杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[11]	刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[12]	张龙, 孙善柯, 徐伟, 李文柱, 李俊达, 池涌泉, 何广胜, 成峰, 王学浩, 饶建华. 腹腔镜脾切除治疗血液系统疾病的临床疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 870-875.
[13]	卓文锋, 曾桂芳, 杨思加, 赵家立, 邹宝嘉, 白子锐, 林恩, 李坚. 腹腔镜巨脾切除术：逐步打破的手术壁垒[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 783-788.
[14]	司楠, 孙洪涛. 创伤性脑损伤后肾功能障碍危险因素的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 300-305.
[15]	颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Influencing factors of portal vein thrombosis after splenectomy in patients with cirrhotic hyperplenism

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Influencing factors of portal vein thrombosis after splenectomy in patients with cirrhotic hyperplenism